Back to
XTX Topco Ltd
TGTX
Showing 8 of 16 quarters
Position history for
XTX Topco Ltd's holdings in TG Therapeutics, Inc.
No. XTX Topco exited its TGTX (TG Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 25,583 shares worth $849,867. XTX Topco first reported TGTX in Q2 2022 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History